Mineralys Therapeutics (MLYS) Equity Average (2022 - 2026)

Quarterly results put Equity Average at $642.4 million for Q1 2026, up 141.14% from a year ago — trailing twelve months through Mar 2026 was $642.4 million (up 141.14% YoY), and the annual figure for FY2025 was $419.0 million, up 93.79%.

Mineralys Therapeutics has reported Equity Average over the past 5 years, most recently at $642.4 million for Q1 2026.

  • Equity Average reached $642.4 million in Q1 2026 per MLYS's latest filing, up from $611.6 million in the prior quarter.
  • Across five years, Equity Average topped out at $642.4 million in Q1 2026 and bottomed at -$47.8 million in Q4 2022.
  • Median Equity Average over the past 5 years was $270.5 million (2023), compared with a mean of $261.4 million.
  • The largest annual shift saw Equity Average surged 961.81% in 2023 before it decreased 15.24% in 2024.
  • Over 5 years, Equity Average stood at -$47.8 million in 2022, then soared by 627.96% to $252.6 million in 2023, then fell by 15.24% to $214.1 million in 2024, then skyrocketed by 185.65% to $611.6 million in 2025, then grew by 5.05% to $642.4 million in 2026.
  • Business Quant data shows Equity Average for MLYS at $642.4 million in Q1 2026, $611.6 million in Q4 2025, and $445.0 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Equity Avg. (Qtr)
1 Quantum Biopharma 1,384,976.65 Bn 1,384,976.64 Bn - 3.76 Mn
2 Alterity Therapeutics 777,208.84 Bn 777,208.81 Bn - -
3 Legend Biotech 2,801.00 Bn 2,800.10 Bn 242.10 Mn -
4 Nanobiotix 2,226.01 Bn 2,225.95 Bn - -
5 Akari Therapeutics 605.66 Bn 605.66 Bn - 21.35 Mn
6 Vertex Pharmaceuticals 110.17 Bn 102.92 Bn 2.59 Bn 19.01 Bn
7 Regeneron Pharmaceuticals 66.86 Bn 58.11 Bn 3.31 Bn 31.34 Bn
8 Evaxion A 65.12 Bn 65.10 Bn - -
9 Alnylam Pharmaceuticals 39.94 Bn 36.94 Bn 959.66 Mn 932.28 Mn
10 Mineralys Therapeutics 2.50 Bn 2.50 Bn - 642.42 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 642.42 Mn
Dec 31, 2025 611.56 Mn
Sep 30, 2025 444.99 Mn
Jun 30, 2025 327.55 Mn
Mar 31, 2025 266.41 Mn
Dec 31, 2024 214.09 Mn
Sep 30, 2024 263.51 Mn
Jun 30, 2024 309.07 Mn
Mar 31, 2024 284.60 Mn
Dec 31, 2023 252.58 Mn
Sep 30, 2023 274.51 Mn
Jun 30, 2023 290.44 Mn
Mar 31, 2023 121.80 Mn
Dec 31, 2022 -47.84 Mn
Sep 30, 2022 -40.17 Mn
Jun 30, 2022 -33.70 Mn